EliMuchtarMD

PubMed

• Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.
  Saurabh Zanwar, Morie A Gertz, Eli Muchtar, Francis K Buadi, Taxiarchis Kourelis, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Moritz Binder, Josell...> ;Leukemia. 2024 Apr 9
• 1 citations
  A proteomic atlas of kidney amyloidosis provides insights into disease pathogenesis.
  Dasari, S., Theis, J., Vrana, J., Leung, N., Ramirez-Alvarado, M., Charalampous, C., McPhail, E., Dispenzieri, A., Muchtar, E., Gertz, M., Kourelis, T.> ;Kidney International. 2024 Mar 1
• Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
  Sarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q Lacy, Morie A Gertz, Francis K Buadi, Suzanne R Hayman, David Din...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Mar 1
• Amino acid sequence homology of monoclonal serum free light chain dimers and tissue deposited light chains in AL amyloidosis: a pilot study.
  Rivka Goldis, Batia Kaplan, Michael Arad, Angela Dispenzieri, Surendra Dasari, Olga Lesya Kukuy, Amos J Simon, Amir Dori, Efrat Shavit-Stein, Tamar Ziv, David Murray, ...> ;Clinical Chemistry and Laboratory Medicine. 2024 Feb 26
• Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
  Samuel R Kosydar, Sameer A Parikh, Scott C Lester, Kari G Rabe, Wei Ding, Jessica F Burlile, Saad S Kenderian, Yucai Wang, Eli Muchtar, Amber B Koehler, Susan M Schwag...> ;American Journal of Hematology. 2023 Nov 1
• 1 citations
  Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
  Walker M Schmidt, Nirosha D Perera, Francis K Buadi, Suzanne R Hayman, Shaji K Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q Lacy, Prashant Kapoor, N...> ;Blood Cancer Journal. 2023 Aug 18
• 2 citations
  Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
  Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia Greipp, Rhett Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafa...> ;Blood. 2023 Nov 30
• 6 citations
  Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
  Saurabh Zanwar, Matthew Ho, Yi Lin, Prashant Kapoor, Moritz Binder, Francis K Buadi, Angela Dispenzieri, David Dingli, Amie Fonder, Morie A Gertz, Wilson Gonsalves, Su...> ;American Journal of Hematology. 2023 Oct 1
• Identifying signs and symptoms of AL amyloidosis in electronic health records using natural language processing, diagnosis codes, and manually abstracted registry data.
  Eli Silvert, Laura Hester, Eshwan Ramudu, Colin Pawlowski, Britte Kranenburg, Francis Buadi, Eli Muchtar, Samer Khaled, Namphuong Tran, Venky Soundararajan, Najat Khan...> ;American Journal of Hematology. 2023 Sep 1
• Gastrointestinal amyloidosis: an often unexpected finding with systemic implications.
  Catherine E Hagen, Surendra Dasari, Jason D Theis, Karen L Rech, Linda N Dao, Matthew T Howard, Angela Dispenzieri, April Chiu, Joanna C Dalland, Paul J Kurtin, Morie ...> ;Human Pathology. 2023 Sep 1
• A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
  Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, Prashant Kapoor, Martha Q Lacy, Morie A Gertz, Francis K Buadi, David Dingli, Rahma Warsame, Taxiarchis Kourelis, ...> ;American Journal of Hematology. 2023 Aug 1
• A novelframeshift mutation Glu120Glyfs*60 with upper gastrointestinal involvement and an indolent course.
  Eli Muchtar, Surendra Dasari, Jason D Theis, Laura Ongie, Huong T Cabral, Ellen D McPhail, Angela Dispenzieri, Morie A Gertz, Karen L Rech> ;Amyloid. 2023 Sep 1
• AL amyloidosis clonal plasma cells are regulated by microRNAs and dependent on anti-apoptotic BCL2 family members.
  Hila Fishov, Eli Muchtar, Mali Salmon-Divon, Angela Dispenzieri, Tal Zvida, Claudio Schneider, Benjamin Bender, Adrian Duek, Merav Leiba, Ofer Shpilberg, Oshrat Hershk...> ;Cancer Medicine. 2023 Apr 1
• 3 citations
  Immunoglobulin Light Chain Amyloidosis: Diagnosis and Risk Assessment.
  Saurabh Zanwar, Morie A Gertz, Eli Muchtar> ;Journal of the National Comprehensive Cancer Network. 2023 Jan 1
• 1 citations
  The impact of Post-Transplant doxycycline in AL amyloidosis - updated results after Long-Term follow up.
  Nadine Abdallah, Angela Dispenzieri, Eli Muchtar, Francis K Buadi, Prashant Kapoor, Martha Q Lacy, Yi L Hwa, Amie Fonder, Miriam A Hobbs, Suzanne R Hayman, Nelson Leun...> ;Amyloid. 2023 Sep 1
• 1 citations
  Second- and third-line treatment strategies in multiple myeloma: a referral-center experience.
  Sarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q Lacy, Morie A Gertz, Francis K Buadi, Suzanne R Hayman, David Din...> ;Blood Cancer Journal. 2022 Dec 6
• Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
  Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood Cancer Journal. 2022 Nov 24
• 3 citations
  Sarcopenia identified by computed tomography imaging using a deep learning-based segmentation approach impacts survival in patients with newly diagnosed multiple myeloma.
  Bharat Nandakumar, Francis Baffour, Nadine H Abdallah, Shaji K Kumar, Angela Dispenzieri, Francis K Buadi, David Dingli, Martha Q Lacy, Suzanne R Hayman, Prashant Kapo...> ;Cancer. 2023 Feb 1
• 15 citations
  Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;American Journal of Hematology. 2023 Jan 1
• 11 citations
  Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis.
  Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan Schönland, Kaya Veelken, Ute Hegenbart, Susan M Geyer,...> ;Journal of Clinical Oncology. 2023 Mar 1
• 2 citations
  Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood. 2022 Nov 3
• 4 citations
  Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
  Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Asher A Chanan-Khan, Saad S Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B Koehler,...> ;Blood Cancer Journal. 2022 Sep 1
• 3 citations
  Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy.
  Mohammad Ebraheem, Shaji K Kumar, Angela Dispenzieri, Dragan Jevremovic, Francis K Buadi, David Dingli, Joselle Cook, Martha Q Lacy, Suzanne R Hayman, Prashant Kapoor,...> ;Transplantation and Cellular Therapy. 2022 Nov 1
• 6 citations
  Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia.
  Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Saad S Kenderian, Eli Muchtar, Yucai Wang, Amber B Koehler, Ricardo Parrondo, Susan M Schwager, Min ...> ;British Journal of Haematology. 2022 Oct 1
• 1 citations
  Serum B-Cell maturation antigen is an independent prognostic marker in previously untreated chronic lymphocytic leukemia.
  Camilia M Soof, Tanya M Spektor, Sameer A Parikh, Susan L Slager, Kari G Rabe, Timothy G Call, Saad S Kenderian, Wei Ding, Eli Muchtar, Matthew Ghermezi, Neil E Kay, J...> ;Experimental Hematology. 2022 Jul 1
• Join now to see all

Journal Articles

• Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell Transplantation  
  Nelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
• Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis  
  Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature
• Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy: Failure of the Serum Free Light Chain Ratio  
  Morie A Gertz, David Dingli, Miriam Hobbs, John A Lust, Ronald S Go, Amie Fonder, Yi Lin, Shaji K Kumar, Prashant Kapoor, Taxiarchis V Kourelis, S Vincent Rajkumar, Ro..., Nature
• Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Centre  
  Sameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology
• Join now to see all

Abstracts/Posters

• Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phase 2 Trial of Daratumumab, Ixazomib, Lenalidomide and Modified Dose Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (C...
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Waldenstr_m Macroglobulinemia with Excess Plasma Cells: Is It a Distinct Entity?
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Impact of sFLC Ratio on Outcome in Patients with MM: Validating the Utility of sFLC in Response Definition
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Optimal Therapy for Relapsed AL Amyloidosis Post Autologous Stem Cell Transplant
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis
  Eli Muchtar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Bortezomib, Lenalidomide and Dexamethasone (VRD) Followed By Autologous Stem Cell Transplant for Newly Diagnosed Multiple Myeloma; The Mayo Clinic Experience 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long-Term Survivorship with Active Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all